Rainer T H, Robertson C E
Royal Infirmary of Edinburgh.
J Accid Emerg Med. 1996 Jul;13(4):234-7. doi: 10.1136/emj.13.4.234.
In this article we review the evidence supporting the clinical application of adrenaline in cardiopulmonary arrest, and summarize the receptor effects of catecholamines and the basic principles producing perfusion during CPR. Animal and human studies show that in cardiac arrest, adrenaline has positive haemodynamic effects, increasing systemic pressures, myocardial perfusion, and cerebrally directed flow. The problems extrapolating from animal to human data are highlighted. Studies showing improvements in short term survival outcomes with high dose regimens have not been confirmed by other large prospective randomised trials. There is no evidence that high doses of adrenaline improve survival to hospital discharge. Most studies comparing adrenaline with placebo have been non-randomised and uncontrolled, with major methodological problems. Conclusions are difficult, but if anything adrenaline is associated with poorer outcomes.
在本文中,我们回顾了支持肾上腺素在心肺复苏中临床应用的证据,并总结了儿茶酚胺的受体效应以及心肺复苏期间产生灌注的基本原则。动物和人体研究表明,在心脏骤停时,肾上腺素具有积极的血流动力学效应,可增加体循环压力、心肌灌注和脑血流。文中强调了从动物数据推断到人类数据存在的问题。显示高剂量方案能改善短期生存结局的研究尚未得到其他大型前瞻性随机试验的证实。没有证据表明高剂量肾上腺素能提高出院存活率。大多数比较肾上腺素与安慰剂的研究未进行随机分组和对照,存在重大方法学问题。很难得出结论,但如果有什么关联的话,肾上腺素与更差的结局相关。